🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
RAD001 is approved by the U.S Food and Drug Administration (FDA) to treat a...
Status
Terminated
Location
Dana-Farber Cancer Institute
Start Date
2010-02
Trial ID
NCT01058408
Treatments Being Tested
RATIONALE: Drugs used in chemotherapy, such as cisplatin, work in different...
Status
Completed
Location
Memorial Sloan-Kettering Cancer Center
Start Date
2006-11
Trial ID
NCT00423865
RATIONALE: Drugs used in chemotherapy, such as cisplatin and paclitaxel, wo...
Status
Completed
Location
Erlanger Cancer Center at Erlanger Hospital - Baroness
Start Date
2009-10
Trial ID
NCT01031446
Treatments Being Tested
Hypothesis: The addition of RAD001 to TS-1/CDDP is safe and can improved th...
Status
Terminated
Location
National University Hospital
Start Date
TBD
Trial ID
NCT01096199
Treatments Being Tested
RATIONALE: Drugs used in chemotherapy, such as cisplatin and paclitaxel, wo...
Status
Completed
Location
Vanderbilt-Ingram Cancer Center - Cool Springs
Start Date
2008-05
Trial ID
NCT00680758
Treatments Being Tested
This study consists of two parts. In a phase Ib part, investigators will ex...
Status
Terminated
Location
National cancer center
Start Date
2013-08
Trial ID
NCT01939418
Treatments Being Tested
This Phase 1, single-site, dose-escalation study is being conducted to dete...
Status
Withdrawn
Location
Multiple Locations
Start Date
2009-12
Trial ID
NCT00967928
Treatments Being Tested
The purpose of this study is to test the safety of gemcitabine and cisplati...
Status
Completed
Location
Memorial Sloan Kettering Cancer Center
Start Date
2010-08
Trial ID
NCT01182168
Treatments Being Tested
The purpose of this study is to test the safety of RAD001 (everolimus) tabl...
Status
Completed
Location
Memorial Sloan-Kettering Cancer Center at Basking Ridge
Start Date
2009-07
Trial ID
NCT00935961
Treatments Being Tested
The purpose of this study is to understand the effects (good and/or bad) of...
Status
Terminated
Location
University of Chicago Medical Center
Start Date
2010-02
Trial ID
NCT01063478
Treatments Being Tested